Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study

Introduction We hypothesized that engineering a combined lymph node/melanoma organoid from the same patient would allow tumor, stroma, and immune system to remain viable for personalized immunotherapy screening.